[1] |
BERZIGOTTI A. Advances and challenges in cirrhosis and portal hypertension[J]. BMC Med, 2017, 15(1): 200. DOI: 10.1186/s12916-017-0966-6.
|
[2] |
GROSS M. Liver cirrhosis and the most common complications: Diagnosis and treatment[J]. MMW Fortschr Med, 2015, 157(Suppl 1): 75-79. DOI: 10.1007/s15006-015-2550-3.
|
[3] |
de FRANCHIS R, Baveno Ⅵ Faculty. Expanding consensus in portal hypertension: Report of the Baveno Ⅵ Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752. DOI: 10.1016/j.jhep.2015.05.022.
|
[4] |
YOO JJ, KIM SG. HVPG as a predictor of mortality in non-critically-ill cirrhotic patients[J]. J Korean Med Sci, 2019, 34(33): e235. DOI: 10.3346/jkms.2019.34.e235.
|
[5] |
AGARWAL S, SHARMA S, ANAND A, et al. Liver stiffness assessment as an alternative to hepatic venous pressure gradient for predicting rebleed after acute variceal bleed: A proof-of-concept study[J]. JGH Open, 2021, 5(1): 73-80. DOI: 10.1002/jgh3.12449.
|
[6] |
POONKHUM R, SHOWPITTAPORNCHAI U, PRADIDARCHEEP W. Collagen arrangement in space of Disse correlates with fluid flow in normal and cirrhotic rat livers[J]. Microsc Res Tech, 2015, 78(2): 187-193. DOI: 10.1002/jemt.22460.
|
[7] |
WEISKIRCHEN R, WEISKIRCHEN S, TACKE F. Recent advances in understanding liver fibrosis: Bridging basic science and individualized treatment concepts[J]. F1000Res, 2018, 7. DOI: 10.12688/f1000research.14841.1.
|
[8] |
WEISKIRCHEN R, WEISKIRCHEN S, TACKE F. Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications[J]. Mol Aspects Med, 2019, 65: 2-15. DOI: 10.1016/j.mam.2018.06.003.
|
[9] |
AYCOCK RS, SEYER JM. Collagens of normal and cirrhotic human liver[J]. Connect Tissue Res, 1989, 23(1): 19-31. DOI: 10.3109/03008208909103901.
|
[10] |
HU DD, HABIB S, LI XM, et al. Angiogenesis: A new surrogate histopathological marker is capable of differentiating between mild and significant portal hypertension[J]. Histol Histopathol, 2015, 30(2): 205-212. DOI: 10.14670/HH-30.205.
|
[11] |
CALVARUSO V, BURROUGHS AK, STANDISH R, et al. Computer-assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient[J]. Hepatology, 2009, 49(4): 1236-1244. DOI: 10.1002/hep.22745.
|
[12] |
TSOCHATZIS E, BRUNO S, ISGRO G, et al. Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis[J]. J Hepatol, 2014, 60(5): 948-954. DOI: 10.1016/j.jhep.2013.12.023.
|
[13] |
SETHASINE S, JAIN D, GROSZMANN RJ, et al. Quantitative histological-hemodynamic correlations in cirrhosis[J]. Hepatology, 2012, 55(4): 1146-1153. DOI: 10.1002/hep.24805.
|
[14] |
ISGRO G, CALVARUSO V, ANDREANA L, et al. The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis[J]. J Gastroenterol, 2013, 48(8): 921-929. DOI: 10.1007/s00535-012-0694-9.
|
[15] |
NIELSEN K, CLEMMESEN JO, VASSILIADIS E, et al. Liver collagen in cirrhosis correlates with portal hypertension and liver dysfunction[J]. APMIS, 2014, 122(12): 1213-1222. DOI: 10.1111/apm.12287.
|
[16] |
KUMAR M, SAKHUJA P, KUMAR A, et al. Histological subclassification of cirrhosis based on histological-haemodynamic correlation[J]. Aliment Pharmacol Ther, 2008, 27(9): 771-779. DOI: 10.1111/j.1365-2036.2008.03653.x.
|
[17] |
RASTOGI A, MAIWALL R, BIHARI C, et al. Cirrhosis histology and Laennec staging system correlate with high portal pressure[J]. Histopathology, 2013, 62(5): 731-741. DOI: 10.1111/his.12070.
|
[18] |
NAGULA S, JAIN D, GROSZMANN RJ, et al. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis[J]. J Hepatol, 2006, 44(1): 111-117. DOI: 10.1016/j.jhep.2005.07.036.
|
[19] |
COSAR AM, YAKAR T, SERIN E, et al. The relationship between fibrosis and nodule structure and esophageal varices[J]. Turk J Gastroenterol, 2019, 30(7): 624-629. DOI: 10.5152/tjg.2019.18665.
|
[20] |
XUAN R, ZHAO X, JIAN J, et al. Phase-contrast computed tomography: A correlation study between portal pressure and three dimensional microvasculature of ex vivo liver samples from carbon tetrachloride-induced liver fibrosis in rats[J]. Microvasc Res, 2019, 125: 103884. DOI: 10.1016/j.mvr.2019.103884.
|
[21] |
GARBUZENKO DV, AREFYEV NO, KAZACHKOV EL. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives[J]. World J Gastroenterol, 2018, 24(33): 3738-3748. DOI: 10.3748/wjg.v24.i33.3738.
|
[22] |
LI H. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma[J]. Expert Rev Gastroenterol Hepatol, 2021, 15(3): 217-233. DOI: 10.1080/17474124.2021.1842732.
|
[23] |
ZADOROZHNA M, DI GIOIA S, CONESE M, et al. Neovascularization is a key feature of liver fibrosis progression: Anti-angiogenesis as an innovative way of liver fibrosis treatment[J]. Mol Biol Rep, 2020, 47(3): 2279-2288. DOI: 10.1007/s11033-020-05290-0.
|
[24] |
GANA JC, SERRANO CA, LING SC. Angiogenesis and portal-systemic collaterals in portal hypertension[J]. Ann Hepatol, 2016, 15(3): 303-313. DOI: 10.5604/16652681.1198799.
|
[25] |
WEIDNER N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147(1): 9-19. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1869874/pdf/amjpathol00043-0015.pdf?origin=publication_detail
|
[26] |
WU Y, LI Z, XIU AY, et al. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice[J]. Drug Des Devel Ther, 2019, 13: 2667-2676. DOI: 10.2147/DDDT.S210797.
|
[27] |
SUN M, LV W, ZHAO X, et al. Vascular branching geometry relating to portal hypertension: A study of liver microvasculature in cirrhotic rats by X-ray phase-contrast computed tomography[J]. Quant Imaging Med Surg, 2020, 10(1): 116-127. DOI: 10.21037/qims.2019.11.04.
|
[28] |
TANAKA M, IWAKIRI Y. Lymphatics in the liver[J]. Curr Opin Immunol, 2018, 53: 137-142. DOI: 10.1016/j.coi.2018.04.028.
|
[29] |
PUPULIM LF, VILGRAIN V, RONOT M, et al. Hepatic lymphatics: Anatomy and related diseases[J]. Abdom Imaging, 2015, 40(6): 1997-2011. DOI: 10.1007/s00261-015-0350-y.
|
[30] |
IWAKIRI Y. Pathophysiology of portal hypertension[J]. Clin Liver Dis, 2014, 18(2): 281-291. DOI: 10.1016/j.cld.2013.12.001.
|
[31] |
TANAKA M, IWAKIRI Y. The hepatic lymphatic vascular system: Structure, function, markers, and lymphangiogenesis[J]. Cell Mol Gastroenterol Hepatol, 2016, 2(6): 733-749. DOI: 10.1016/j.jcmgh.2016.09.002.
|
[32] |
BARROWMAN JA, GRANGER DN. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat[J]. Gastroenterology, 1984, 87(1): 165-172. http://www.valueinhealthjournal.com/article/0016-5085(84)90140-9/pdf
|
[33] |
VOLLMAR B, WOLF B, SIEGMUND S, et al. Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis[J]. Am J Pathol, 1997, 151(1): 169-175. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857941/pdf/amjpathol00019-0168.pdf
|
[34] |
TANAKA M, IWAKIRI Y. The hepatic lymphatic vascular system: Structure, function, markers, and lymphangiogenesis[J]. Cell Mol Gastroenterol Hepatol, 2016, 2(6): 733-749. DOI: 10.1016/j.jcmgh.2016.09.002.
|
[35] |
YAMAUCHI Y, MICHITAKA K, ONJI M. Morphometric analysis of lymphatic and blood vessels in human chronic viral liver diseases[J]. Am J Pathol, 1998, 153(4): 1131-1137. DOI: 10.1016/S0002-9440(10)65657-X.
|
[36] |
TAMBURINI B, FINLON JM, GILLEN AE, et al. Chronic liver disease in humans causes expansion and differentiation of liver lymphatic endothelial cells[J]. Front Immunol, 2019, 10: 1036. DOI: 10.3389/fimmu.2019.01036.
|
[37] |
OIKAWA H, MASUDA T, SATO S, et al. Changes in lymph vessels and portal veins in the portal tract of patients with idiopathic portal hypertension: A morphometric study[J]. Hepatology, 1998, 27(6): 1607-1610. DOI: 10.1002/hep.510270621.
|
[38] |
PARK SW, KIM TH, HAM SY, et al. Clinical implications of thoracic duct dilatation in patients with chronic liver disease[J]. Medicine (Baltimore), 2020, 99(22): e19889. DOI: 10.1097/MD.0000000000019889.
|
[39] |
DAINA CM, DAINA LG, BONTA M, et al. Study concerning the histopathological changes in chronic hepatopathies[J]. Rom J Morphol Embryol, 2017, 58(1): 153-159. http://www.rjme.ro/RJME/resources/files/580117153159.pdf
|
[40] |
NGUYEN T, TANG W, NAN L, et al. The role of bile duct reactive change in the pathogenesis of liver fibrosis due to hepatitis C[J]. Exp Mol Pathol, 2005, 79(2): 95-99. DOI: 10.1016/j.yexmp.2005.04.010.
|
[41] |
GLASER SS, GAUDIO E, MILLER T, et al. Cholangiocyte proliferation and liver fibrosis[J]. Expert Rev Mol Med, 2009, 11: e7. DOI: 10.1017/S1462399409000994.
|
[42] |
SATO K, MARZIONI M, MENG F, et al. Ductular reaction in liver diseases: Pathological mechanisms and translational significances[J]. Hepatology, 2019, 69(1): 420-430. DOI: 10.1002/hep.30150.
|
[43] |
HUBEL E, SAROHA A, PARK WJ, et al. Sortilin deficiency reduces ductular reaction, hepatocyte apoptosis, and liver fibrosis in cholestatic-induced liver injury[J]. Am J Pathol, 2017, 187(1): 122-133. DOI: 10.1016/j.ajpath.2016.09.005.
|
[44] |
HALL C, SATO K, WU N, et al. Regulators of cholangiocyte proliferation[J]. Gene Expr, 2017, 17(2): 155-171. DOI: 10.3727/105221616X692568.
|
[45] |
RÓKUSZ A, VERES D, SZVCS A, et al. Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models[J]. PLoS One, 2017, 12(4): e0176518. DOI: 10.1371/journal.pone.0176518.
|
[46] |
WOOD MJ, GADD VL, POWELL LW, et al. Ductular reaction in hereditary hemochromatosis: The link between hepatocyte senescence and fibrosis progression[J]. Hepatology, 2014, 59(3): 848-857. DOI: 10.1002/hep.26706.
|
[47] |
CLOUSTON AD, POWELL EE, WALSH MJ, et al. Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis[J]. Hepatology, 2005, 41(4): 809-818. DOI: 10.1002/hep.20650.
|
[48] |
RICHARDSON MM, JONSSON JR, POWELL EE, et al. Progressive fibrosis in nonalcoholic steatohepatitis: Association with altered regeneration and a ductular reaction[J]. Gastroenterology, 2007, 133(1): 80-90. DOI: 10.1053/j.gastro.2007.05.012.
|